Background and Purpose-The long-standing concept that delayed cerebral infarction after aneurysmal subarachnoid hemorrhage results exclusively from large artery vasospasm recently has been challenged. We used data from the CONSCIOUS-1 trial to determine the relationship between angiographic vasospasm and cerebral infarction after subarachnoid hemorrhage. Methods-We performed a post hoc exploratory analysis of the CONSCIOUS-1 data. All patients underwent catheter angiography before treatment and 9Ϯ2 days after subarachnoid hemorrhage. CT was performed before and after aneurysm treatment, and 6 weeks after subarachnoid hemorrhage. Angiograms and CT scans were assessed by centralized blinded review. Angiographic vasospasm was classified as none/mild (0%-33% decrease in arterial diameter), moderate (34%-66%), or severe (Ն67% 
C erebral arterial or angiographic vasospasm after aneurysmal subarachnoid hemorrhage (SAH) is considered a leading preventable cause of morbidity and mortality in patients who experience aneurysmal rupture. [1] [2] [3] [4] [5] Vasospasm contributes to poor outcome by causing cerebral infarction. 6 Cerebral infarction, in turn, is strongly associated with poor outcome after aneurysmal SAH. 2, [7] [8] [9] [10] In recent years, however, the role of abnormalities at the microvascular and tissue level in producing ischemic injury after SAH has gained increasing attention. Distal small-artery vasospasm is readily visible on angiography and has been correlated with prolonged circulation times. 11 Microcirculatory dysfunction related to endothelial damage, microvascular thrombosis, and loss of autoregulation have been implicated in the pathogenesis of delayed cerebral ischemia. 5, 12 Cortical spreading depolarizations have been documented in poorgrade SAH patients and have been linked to brain energy failure and ischemic injury. 13 The lack of correlation between prevention of angiographic vasospasm and improvement in clinical outcome in clinical trials has led to the suggestion that angiographic vasospasm is an epiphenomenon that does not cause poor outcome. 5 For example, the clazosentan to overcome neurological ischemia and infarct occurring after subarachnoid hemorrhage (CONSCIOUS-1) study demonstrated that the endothelin receptor-A antagonist clazosentan prevented angiographic vasospasm but did not reduce mortality or improve outcome. 14 The sample size estimates for this study were not derived to demonstrate an effect on patient-centered outcome, but the results still raise this question. The present post hoc exploratory analysis of the CONSCIOUS-1 data was performed to examine the relationship between angiographic vasospasm and cerebral infarction. The data are unique in that angiographic vasospasm was assessed directly in almost all patients without contamination by inaccurate transcranial Doppler ultrasound results or investigation of only selected patients.
Patients and Methods
The main results of the CONSCIOUS-1 study have been published. 14 This was an international, multicenter, randomized, prospective, phase 2, dose-finding trial that examined the efficacy and safety of the endothelin A receptor antagonist clazosentan for the prevention of vasospasm after aneurysmal SAH. Four hundred thirteen patients were randomized and data necessary for this analysis were obtained for 381.
All patients underwent baseline catheter angiography within 48 hours of SAH but before aneurysm treatment and 9Ϯ2 days after SAH. Cranial CT was performed on all patients within 48 hours of SAH, 24 to 48 hours after the aneurysm-securing procedure, and 6 weeks after SAH.
Angiographic vasospasm was assessed by blinded, centralized review of baseline and follow-up angiograms by 2 independent reviewers and differences of opinion were adjudicated by a third reviewer. The severity of vasospasm was considered none or mild if a 0% to 33% decrease in arterial diameter was observed on the day 9Ϯ2 angiogram, moderate if there was a 34% to 66% decrease, or severe if there was a decrease in arterial diameter of Ն67%.
Hypodensities on CT scans were assessed by 2 independent reviewers who were blinded to each other's results and to the study treatment group, but who had access to all CT scans and angiograms. The etiology of hypodensities was determined by comparing the CT scan obtained 6 weeks after SAH to the CT scan taken on admission and 24 to 48 hours after the aneurysm-securing procedure. If a hypodensity were present, then each reviewer categorized it as attributable to angiographic vasospasm, other known causes (procedure-related, encephalomalacia from intracerebral hemorrhage or ventricular drain, other causes), or unknown. Differences of opinion were adjudicated between the 2 reviewers by consensus. For this analysis, cerebral infarction was defined as hypodensity in an arterial territory or watershed distribution on CT scan at 6 weeks, not present on the admission or 24-to 48-hour CT scan, and considered attributable to vasospasm (the angiographic vasospasm category) or unknown causes. Cerebral infarction attributable to unknown causes was included to avoid bias caused by the circular reasoning of including infarction only if angiographic vasospasm was observed.
Rescue therapy was defined as use of hemodynamic therapy or angioplasty within 14 days of SAH in the presence of vasospasm on catheter angiography or transcranial Doppler.
Statistical Analysis
The relation of cerebral infarction to severity of angiographic vasospasm was tabulated based on the opinion of each reviewer and results are shown for 1 reviewer. The analyses were performed for patients with complete data (nϭ381) and imputed data (nϭ413). The imputation rule assumed severe angiographic vasospasm if the presence or absence of vasospasm could not be determined from the central reading. The exception to this rule was that no angiographic vasospasm was imputed if the patient was alive at 6-week follow-up, had no transcranial Doppler ultrasound findings suggestive of vasospasm, and had no neurological worsening. Tabular data were compared by the 2 test. Bivariate and multivariate logistic regression analyses were performed to determine variables associated with cerebral infarction. Some multivariate analyses adjusted for age, World Federation of Neurosurgical Societies grade, gender, history of hypertension, subarachnoid clot size, intraparenchymal hemorrhage, intraventricular hemorrhage, hydrocephalus, aneurysm size, and aneurysm location. Data are meansϮSD, and PϽ0.05 was considered significant.
Results
According to consensus review, there were 43 infarctions attributable to angiographic vasospasm or other causes among 381 patients (11%). Angiographic vasospasm was classified as none/mild in 209 (55%), moderate in 118 (31%), and severe in 54 (14%) of the 381 patients (Table 1) . According to 1 reviewer, infarction attributable to vasospasm was present in 2 of 209 (1%) patients with no/mild, 11 of 118 (9%) with moderate, and 25 of 54 (46%) with severe vasospasm. Infarction attributable to unknown causes was reported by that reviewer in 4 (2%) of patients with no/mild, 1 (1%) with moderate, and no patients with severe vasospasm. Combining these categories showed an increase in infarcts from 6 (3%) of 209 patients with no/mild, 12 (10%) of 118 patients with moderate, and 25 (46%) of 54 patients with severe vasospasm. Also, 81% (37 of 43) of infarcts occurred in patients with moderate or severe vasospasm and 58% (25 of 43) in patients with severe vasospasm. There was a significant relationship between severity of vasospasm and proportion of patients with infarction ( 2 ϭ81; PϽ0.001). Imputation or use of data from the other reviewer gave virtually identical results (data not shown).
Use of rescue therapy was examined because this might influence whether angiographic vasospasm caused infarction (Table 2 ). Most infarcts (60%; 26 of 43) were seen in the group who received rescue therapy ( 2 ϭ8.6; Pϭ0.013), although all 5 infarcts attributable to unknown causes were in patients with no, mild, or moderate angiographic vasospasm and no rescue therapy. The relation between cerebral infarction and type of aneurysm-securing procedure was also examined. There was no significant difference in the number of vasospasm-related infarctions or total infarctions between patients undergoing neurosurgical clipping or endovascular treatment (Table 3) .
Bivariate analysis found that variables associated with cerebral infarction were angiographic vasospasm, World Federation of Neurological Societies grade 4 to 5, subarachnoid clot size, aneurysm size (0 -5 versus 6 -15 mm), and intraparenchymal hemorrhage. Multivariate logistic regression found that there was a strong and significant association between angiographic vasospasm and new cerebral infarctions (Table 4 ; PϽ0.0001). Other variables significantly associated with infarction were World Federation of Neurological Societies grade 4 to 5 and aneurysm size. The results were the same using imputed data or data from the other reviewer, except that age also was significantly associated with infarction according to the second reviewer.
Discussion
These data strongly associate angiographic vasospasm with cerebral infarction after SAH. In addition, the severity of vasospasm correlated with the risk of cerebral infarction developing. Although there have been a number of studies discussing the relationship between cerebral infarction and various forms of vasospasm, few attempts have been made to correlate the severity of vasospasm with cerebral infarction. 11 Studies have examined the relation between symptomatic vasospasm, defined in various ways, and cerebral infarction. 8, 9, [15] [16] [17] [18] [19] As early as 1981, Ohta and Ito 20 reported a correlation between angiographic vasospasm and cerebral infarction. Subsequent studies reported associations of cerebral infarction with vasospasm defined by transcranial Doppler criteria and/or clinical findings. 9, 10, 19 These studies, however, are not optimal for assessment of the relation of angiographic vasospasm to infarction for several reasons. Transcranial Doppler correlates with angiographic vasospasm only slightly better than chance, and clinical deterioration could be secondary to infarction from many causes. 21 If angiography is performed selectively when delayed cerebral ischemia occurs, then the association between angiographic vasospasm and delayed cerebral ischemia may be strengthened or weakened. Infarction can be asymptomatic in comatose or sedated patients, which will decrease the correlation between symptomatic vasospasm and infarction, leading to erroneous conclusions that angiographic vasospasm does not correlate with infarction and clinical outcome. 18 We found 2 previous publications describing correlations similar to those reported here. 6, 11 Weidauer et al 11 correlated angiographic vasospasm and infarction in 112 patients with aneurysmal SAH. They excluded procedure-related infarcts and found that 53% of patients with severe angiographic vasospasm (Ͼ66% arterial narrowing) had infarcts develop; 81% of all infarcts were in patients with severe (Ͼ66%), 16% were in those with moderate (34%-66%), and 3% were in patients with no or mild angiographic vasospasm. Dankbaar et al 6 studied 37 patients with aneurysmal SAH. The severity of vasospasm was measured on CT angiography and correlated with CT perfusion and delayed cerebral ischemia. Delayed cerebral ischemia was defined as clinical deterioration lasting Ͼ2 hours and not attributable to rebleeding, hydrocephalus or other medical causes. CT perfusion decreased and the incidence of delayed cerebral ischemia increased as the severity of vasospasm increased.
A retrospective analysis of 143 patients with aneurysmal SAH was consistent with the present findings in that cerebral infarction was significantly associated with angiographic vasospasm in multivariate analysis. 8 The discrepancy, however, was that angiographic vasospasm was not detected in 33% (19 of 57) of patients with infarcts. Explanations provided by the authors were that angiography may not have been conducted during the time of vasospasm in some cases or that other processes could cause infarction in these cases, such as small-vessel spasm and microthromboembolism. Another mechanism may be cortical spreading ischemia. 13 Each of these processes also may contribute to delayed cerebral ischemia and poor outcome independent of or by interacting with angiographic vasospasm. It also may be difficult to ensure that an infarct is not caused by other mechanisms such as perforator occlusion attributable to the aneurysm-securing procedure or a complication of catheter angiography. In the report by Weidauer et al, 11 infarcts in patients with no or mild angiographic vasospasm were seen in only 3% of cases, which is more consistent with the present results.
The limitations of this article include that CT scanning was used to detect infarction. MRI is a more sensitive test for detecting ischemia. One study found infarcts in 31% (39 of 125 patients) with aneurysmal SAH by CT scanning and in 58% (73 of 125) by MRI. 15 Even though more infarcts are detected, the correlation between angiographic vasospasm and infarction on MRI was the same according to Weidauer et al. 11 We do not rule out the possibility of other causes of infarction after SAH. Several studies have detected laminar cortical infarctions in a small proportion of patients with SAH. 13, 22 The infarcts are usually adjacent to areas of thick SAH and may occur without documented angiographic vasospasm. A source of bias might be that the reviewers in this study saw the catheter angiograms, and attributing an infarction to vasospasm usually requires documentation of vasospasm on the angiogram. To avoid circular reasoning, we included all unknown infarctions. There were only 5 of these according to one and 15 according to the other reviewer. Including them did not significantly alter the results. One could speculate that these are attributable to microcirculatory changes, although this would not be favorable to the theory that these alone contribute strongly to infarction because they occur in only approximately 5% of the patients. We also have not correlated the location of angiographic vasospasm with the location and size of the cerebral infarction.
Conclusions
Angiographic vasospasm was strongly correlated with cerebral infarction in the CONSCIOUS-1 data. Why clinical outcome did not improve in that study, despite a significant reduction in angiographic vasospasm, is probably because of the small sample size; the study was not powered to assess clinical outcome and the insensitivity of the dichotomous Glasgow outcome scale. 23, 24 These results cannot rule out the possibility that angiographic vasospasm is an epiphenomenon or marker of some associated process that is itself the true cause of infarction, but this is only possible if the other process is strongly associated with angiographic vasospasm but not amenable to treatments that successfully decrease angiographic vasospasm.
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